If you are still exploring whether a GLP-1 program is the right fit, our free assessment quiz is a simple place to begin
As of April 2026, Zepbound (tirzepatide) appears on the formulary with the following restrictions: Covered indications: Type 2 diabetes mellitus as an adjunct to diet and exercise Must be prescribed by a TRICARE-authorized provider Requires prior authorization regardless of plan type Subject to step therapy requirements (metformin, sulfonylureas, or other first-line agents must be tried first) Excluded indications: Obesity or weight management in patients without type 2 diabetes Overweight status (BMI 25 to 29.9) Metabolic syndrome without diagnosed diabetes Prediabetes (HbA1c 5.7% to 6.4%) Cardiovascular risk reduction in non-diabetic patients The distinction matters because Zepbound is FDA-approved for both chronic weight management (approved December 2023) and type 2 diabetes (approved May 2022 under the brand name Mounjaro)
Start with GLP-1 If You want excellent results at lower cost
Related Reading Can Semaglutide Cause Depression Does Semaglutide Cause Hair Loss How Long Does Compounded Semaglutide Last in the Fridge Semaglutide Weight Loss Side Effects Who Should Not Take Semaglutide Semaglutide Eye Side Effects Compounded Semaglutide Side Effects Semaglutide Belly Fat Liraglutide vs Semaglut How to Choose the Right Tracking App for Your Goals The right app depends on your current challenges
Our physicians monitor your response carefully through regular follow-ups and sleep quality assessments to optimize sleep benefits while minimizing any adaptation effects
And at the end of the day, when were talking about mast cells, progesterone can stabilize mast cells